October 13, 2011
A Pharmaceutical Product Development Inc. shareholder filed a putative class action Tuesday in North Carolina federal court seeking to block a $3.9 billion bid by private equity buyers The Carlyle Group LP and Hellman & Friedman LLC to take the research company private.